David McMullin
2018
In 2018, David McMullin earned a total compensation of $1.6M as Chief Commercial Officer at Aldeyra Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $70,479 |
|---|---|
| Option Awards | $1,279,034 |
| Salary | $234,932 |
| Total | $1,584,445 |
McMullin received $1.3M in option awards, accounting for 81% of the total pay in 2018.
McMullin also received $70.5K in non-equity incentive plan and $234.9K in salary.
Rankings
In 2018, David McMullin's compensation ranked 6,898th out of 14,244 executives tracked by ExecPay. In other words, McMullin earned more than 51.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,898 out of 14,244 | 52nd |
Division Manufacturing | 2,645 out of 5,762 | 54th |
Major group Chemicals And Allied Products | 999 out of 2,125 | 53rd |
Industry group Drugs | 840 out of 1,814 | 54th |
Industry Pharmaceutical Preparations | 655 out of 1,388 | 53rd |
Source: SEC filing on April 22, 2019.
McMullin's colleagues
We found three more compensation records of executives who worked with David McMullin at Aldeyra Therapeutics in 2018.